Outcomes of Robotic MIDCAB With Hybrid PCI for Multivessel Coronary Disease Involving the Left Main: Results of 62 Cases

被引:0
|
作者
Naito, Noritsugu [1 ]
Ibrahim, Homam [2 ]
Staniloae, Cezar [2 ]
Razzouk, Louai [2 ]
Dorsey, Michael [1 ]
Grossi, Eugene [1 ]
Loulmet, Didier F. [1 ]
机构
[1] NYU Langone Hlth, Dept Cardiothorac Surg, 530 First Ave,Suite 9V, New York, NY 10016 USA
[2] NYU Langone Hlth, Dept Cardiol, New York, NY USA
关键词
hybrid coronary revascularization; robotic MIDCAB; PCI; multivessel coronary disease; ARTERY-BYPASS; SAPHENOUS-VEIN; PERIOPERATIVE OUTCOMES; RANDOMIZED-TRIAL; 5-YEAR OUTCOMES; REVASCULARIZATION; INTERVENTION; STENOSIS; PATENCY; SURGERY;
D O I
10.1177/15569845251324200
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Hybrid coronary revascularization is a clinical strategy that uses a combination of surgical revascularization and percutaneous coronary intervention (PCI). Data on the hybrid approach for coronary artery disease involving the left main (LM) are scarce. We analyzed our cohort of hybrid coronary revascularizations with minimally invasive direct coronary artery bypass (MIDCAB) using robotic left internal mammary artery harvesting and PCI for multivessel disease with and without LM involvement.Methods: Between January 2013 and December 2020, 105 patients consecutively underwent robotic MIDCAB. Of those, 62 patients (59.1%) had multivessel coronary artery disease and underwent revascularization via the hybrid approach using robotic MIDCAB and PCI. Patients were then stratified into 2 groups for comparison: LM disease (n = 22, 35.5%) and non-LM disease (n = 40, 64.5%).Results: The SYNTAX scores were significantly lower in the non-LM group compared with the LM group (19.06 +/- 6.41 vs 24.86 +/- 7.04, P = 0.002). There were no other significant differences in demographics between the groups. There were no 30-day mortalities in either group. Freedom from major adverse cardiac and cerebrovascular events at 5 years was 72.2% in the non-LM group and 61.0% in the LM group (P = 0.89). There were no significant differences in 5-year overall survival (94.1% vs 83.3%, P = 0.074) or freedom from coronary reintervention (83.4% vs 75.4%, P = 0.699).Conclusions: Hybrid robotic MIDCAB for patients with and without LM disease can be performed with acceptable results in selected patients. However, it is not possible to draw definitive conclusions regarding safety and efficacy compared with conventional coronary artery bypass grafting.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Prognostic Value of Quantitative Flow Ratio Based Functional SYNTAX Score in Patients With Left Main or Multivessel Coronary Artery Disease
    Zhang, Rui
    Song, Chenxi
    Guan, Changdong
    Liu, Qianqian
    Wang, Chunyue
    Xie, Lihua
    Sun, Zhongwei
    Cai, Minsi
    Zhang, Min
    Wang, Huan
    Liu, Jian
    Dou, Kefei
    Xu, Bo
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (10) : E009155
  • [32] Impact of Stenting Technique and Bifurcation Anatomy on Long-Term Outcomes of PCI for Distal Unprotected Left Main Coronary Disease
    Ng, William
    Lundstrom, Robert
    McNulty, Edward
    JOURNAL OF INVASIVE CARDIOLOGY, 2013, 25 (01) : 23 - 27
  • [33] Transradial Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main and/or Multivessel Disease in Patients With Acute Coronary Syndrome
    Gao, Fei
    Zhou, Yu Jie
    Wang, Zhi Jian
    Yan, Zhen Xian
    Liu, Xiao Li
    Shen, Hua
    ANGIOLOGY, 2016, 67 (01) : 83 - 88
  • [34] Long-term Outcomes of Coronary Artery Bypass Grafting in Veterans with Left Main Coronary Artery Disease
    Chen, Sheena W.
    Rosenfeld, Ethan
    Lee, K. Benjamin
    Napolitano, Michael
    Sparks, Andrew D.
    Panting-Crespo, Jeffrey
    Trachiotis, Gregory D.
    HEART SURGERY FORUM, 2020, 23 (04) : E531 - E536
  • [35] Hybrid revascularisation in multivessel coronary artery disease: could a combination of CABG and PCI be the best option in selected patients?
    Wrigley, Benjamin J.
    Dubey, Gopal
    Spyt, Tom
    Gershlick, Anthony H.
    EUROINTERVENTION, 2013, 8 (11) : 1335 - 1341
  • [36] Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
    Xin, Xiaojun
    Wang, Xiangming
    Dong, Xuesi
    Fan, Yuanming
    Shao, Wei
    Lu, Xiang
    Xiao, Pingxi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Waldo, Stephen W.
    Secemsky, Eric A.
    O'Brien, Cashel
    Kennedy, Kevin F.
    Pomerantsev, Eugene
    Sundt, Thoralf M., III
    McNulty, Edward J.
    Scirica, Benjamin M.
    Yeh, Robert W.
    CIRCULATION, 2014, 130 (25) : 2295 - 2301
  • [38] Evaluation of Early and Midterm Results of Offpump Coronary Artery Bypass in Patients with Left Main Disease
    Imamaki, Mizuho
    Matsuura, Kaoru
    Sakurai, Manabu
    Shimura, Hitoshi
    Ishida, Atsushi
    Miyazaki, Masaru
    JOURNAL OF CARDIAC SURGERY, 2009, 24 (02) : 162 - 166
  • [39] The impact of right coronary artery support on outcomes of patients with unprotected left main disease undergoing percutaneous coronary intervention
    Skorupski, Wojciech Jan
    Grygier, Marek
    Araszkiewicz, Aleksander
    Skorupski, Wlodzimierz
    Grajek, Stefan
    Pyda, Malgorzata
    Siniawski, Andrzej
    Mitkowski, Przemyslow
    Lesiak, Maciej
    Kaluzna-Oleksy, Marta
    KARDIOLOGIA POLSKA, 2021, 79 (06) : 631 - 637
  • [40] Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
    Chen, Xue
    Zhang, Xuehui
    Yan, Yunfeng
    Zhao, Xin
    Nie, Maoxiao
    Feng, Tingting
    Liang, Zhe
    Zhao, Quanming
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2020, 2020